-+ 0.00%
-+ 0.00%
-+ 0.00%
Johnson & Johnson model projects lower lifetime costs with Impella versus balloon pump in high-risk PCI
Share
Listen to the news
Johnson & Johnson model projects lower lifetime costs with Impella versus balloon pump in high-risk PCI
  • Johnson & Johnson will present 26 Impella heart pump abstracts at TCT 2026, running Oct. 31-Nov. 3 in San Diego.
  • A model projects lower lifetime healthcare costs and better quality-adjusted survival versus intra-aortic balloon pumps for heart failure patients undergoing high-risk PCI.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending